4 completed, 1 not yet recruiting. 5 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 5 | Completed 4, Not yet recruiting 1 |
Follow Puberty, Precocious: new trials by email Literature Review of Puberty, Precocious trials Research Report on Puberty, Precocious
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| (Z)-Endoxifen in Girls With MAS-Associated Peripheral Precocious Puberty (Z)-endoxifen - Precocious Puberty, Gonadotropin-dependent | Phase 2 | Not yet recruiting | Atossa Therapeutics, Inc. | 6 | 2027-03-01 | 2026-10-09 |
| Faslodex in McCune-Albright Syndrome Fulvestrant - Puberty, Precocious, McCune-Albright Syndrome | Phase 2 | Completed | AstraZeneca | 30 | 2006-01-31 | 2024-03-05 |
| Pediatrics Testotoxicosis Study [Bicalutamide Anastrozole Treatment for Testotoxicosis] Bicalutamide, Anastrozole - Puberty, Precocious | Phase 2 | Completed | AstraZeneca | 14 | 2004-11-22 | 2018-06-26 |
| Treatment of Boys With Precocious Puberty Spironolactone, Testolactone, Deslorelin - Precocious Puberty | Phase 2 | Completed | Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) | 80 | 1985-01-01 | 2008-03-04 |
| Testolactone for the Treatment of Girls With LHRH Resistant Precocious Puberty Testolactone - Polyostotic Fibrous Dysplasia, Precocious Puberty | Phase 2 | Completed | Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) | 100 | 1982-10-01 | 2008-03-04 |
Fibrous Dysplasia, Polyostotic (2) · Familial Testotoxicosis (1)
Endocrine System Diseases (5) · Gonadal Disorders (5) · Bone Diseases (2) · Bone Diseases, Developmental (2) · Fibrous Dysplasia of Bone (2) · Musculoskeletal Diseases (2) · Osteochondrodysplasias (2)
Testolactone (2) · 4-hydroxy-N-desmethyltamoxifen (1) · Anastrozole (1) · Fulvestrant (1) · Spironolactone (1) · bicalutamide (1) · deslorelin (1)
AstraZeneca (2) · Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) (2) · Atossa Therapeutics, Inc. (1)
United States (5) · France (2) · Russia (2) · United Kingdom (2) · Canada (1) · Germany (1) · India (1) · Italy (1)
Alison Boyce, MD (1) · Yuri E Rukazenkov, MD (1)
2005 (1)